Adverse events and oncotargeted kinase inhibitors /
Saved in:
Main Authors: | |
---|---|
Corporate Authors: | |
Published: |
Academic Press,
|
Publisher Address: | Amsterdam : |
Publication Dates: |
[2017] ©2017 |
Literature type: | eBook |
Language: | English |
Subjects: | |
Online Access: |
https://www.sciencedirect.com/science/book/9780128094006 http://www.sciencedirect.com/science/book/9780128094006 |
Carrier Form: | 1 online resource (xix, 715 pages) |
Bibliography: | Includes bibliographical references and index. |
ISBN: |
9780128094457 0128094451 |
Index Number: | RC271 |
CLC: | R730.54 |
Contents: | Introduction -- Kinases -- Kinase inhibitors -- Adverse events -- Imantinib -- Gefitinib -- Erlotinib -- Sorafenib -- Sunitinib -- Dasatinib -- Lapatinib -- Nilotinib -- Pazopanib -- Vandetanib -- Vemurafenib -- Crizotinib -- Ruxolitinib -- Axitinib -- Bosutinib -- Regorafenib -- Cabozantinib -- Ponatinib -- Dabrafenib -- Trametinib -- Afatinib -- Idelaisib -- Ibrutinib -- Overview -- Conclusion and perspectives. |